본문 바로가기
KERD
논문KCI 등재

CCR2-64I and CCR5Δ32 Polymorphisms in Korean Patients with Myasthenia Gravis

0

조회

0

다운로드

0

인용

0

참고문헌

참고문헌 (31)

  1. Feferman T, "Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis", 174, pp.5324~5331 (2005)
  2. Huang D, "Polymorphisms in IL-1beta and IL-1 receptor antagonist genes are associated with myasthenia gravis", 81, pp.76~81 (1998)
  3. Huang DR, "Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis", 94, pp.165~171 (1999)
  4. Huang D, "Genetic association of Ctla-4 to myasthenia gravis with thymoma", 88, pp.192~198 (1998)
  5. Vieira MA, "Identification by genomic typing of non-DR3 HLA class II gene associated with myasthenia gravis", pp.115~122
  6. van der Pol WL, "Association of the Fc gamma receptor IIA-R", R131 genotype with myasthenia gravis in Dutch patients, 2003, pp.144, 143~147
  7. Giraud M, "Association of the gene encoding the delta-subunit of the muscle acetylcholine receptor (CHRND) with acquired autoimmune myasthenia gravis", 5, pp.80~83 (2004)
  8. Bonifati DM, "Lack of association between acetylcholine receptor epsilon polymorphisms and early-onset myasthenia gravis", 29, pp.436~439 (2004)
  9. Luster AD, "Chemokines-chemotactic cytokines that mediate inflammation", 338, pp.436~445 (1998)
  10. Zhao X, "Genotypes of CCR2 and CCR5 chemokine receptors in human myasthenia gravis", 12, pp.749~753 (2003)
  11. Strieter RM, Standiford TJ, Huffnagle GB, Colletti LM, Lukacs NW, Kunkel SL, "“The good, the bad, and the ugly.” The role of chemokines in models of human disease", 156, pp.3583~3586 (1996)
  12. Miyagishi R, "Identification of cell types producing RANTES, MIP-1 alpha and MIP-1 beta in rat experimental autoimmune encephalomyelitis by in situ hybridization", 77, pp.17~26 (1997)
  13. Favorova OO, "The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4-positive Russians", 59, pp.1652~1655 (2002)
  14. Saito R, "Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients", 170(dera h), pp.172~178 (2005)
  15. Petrek M, "CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis", 162, pp.1000~1003 (2000)
  16. Wang FS, "Population survey of CCR5 delta32, CCR5 m303, CCR2b 64I, and SDF1 3’A allele frequencies in indigenous Chinese healthy individuals, and in HIV-1- infected and HIV-1-uninfected individuals in HIV-1 risk groups", 32, pp.124~130 (2003)
  17. De Pinho Lott Carvalhaes FA, "Distribution of CCR5-delta32, CCR2-64I, SDF1-3’A mutations in populations from the Brazilian Amazon Region", 76, pp.643~646 (2004)
  18. Gharagozloo M, "The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population", 96, pp.277~281 (2005)
  19. Oh MD, "The frequency of mutation in CCR5 gene among Koreans", 11, pp.266~267 (2000)
  20. Martison JJ, "Global distribution of the CCR2-64I", CCR5-59653T HIV-1 disease-protective haplotype, 2000, pp.14, 483~489
  21. Poea-Guyon S, "Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis", 174, pp.5941~5949 (2005)
  22. Shi FD, "Cellular mRNA expression of interferon-gamma (IFN- gamma), IL-4 and IL-10 relates to resistance to experimental autoimmune myasthenia gravis (EAMG) in young Lewis rats", 108, pp.523~528 (1997)
  23. Reyes-Reyna S, "Chemokine production by rat myocytes exposed to interferon-gamma", 94, pp.105~113 (2000)
  24. Charo IF, "Molecular cloning and functional expressionof two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails", pp.2752~2756
  25. Gu D, "Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction", 181, pp.547~557 (1995)
  26. Rottman JB, "Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection", 151, pp.1341~1351 (1997)
  27. Reyes-Reyna S, "Muscle responds to an antibody reactive with the acetylcholine receptor by up-regulating monocyte chemoattractant protein 1: a chemokine with the potential to influence the severity and course of experimental myasthenia gravis", 169, pp.1579~1586 (2002)
  28. Broder CC, "Chemokine receptors and HIV", 62, pp.20~29 (1997)
  29. Siebert H, "The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system", 110, pp.177~185 (2000)
  30. Galimberti D, "CCR2-64I polymorphism and CCR5 Delta32 deletion in patients with Alzheimer’s disease", 225, pp.79~83 (2004)
  31. Adams RN, "Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis", pp.769~775

관련 논문AI추천

이 간행물의 다른 논문 (9건)